BioNexus Gene Lab Corp. (BGLC)
NASDAQ: BGLC · Real-Time Price · USD
0.300
+0.014 (5.04%)
At close: Nov 20, 2024, 4:00 PM
0.310
+0.010 (3.33%)
After-hours: Nov 20, 2024, 7:54 PM EST
BioNexus Gene Lab Market Cap
BioNexus Gene Lab has a market cap or net worth of $5.39 million as of November 21, 2024. Its market cap has decreased by -23.09% in one year.
Market Cap
5.39M
Enterprise Value
1.50M
1-Year Change
-23.09%
Ranking
Category
Stock Price
$0.30
Market Cap Chart
Since September 16, 2020, BioNexus Gene Lab's market cap has decreased from $42.12M to $5.39M, a decrease of -87.20%. That is a compound annual growth rate of -38.86%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 19, 2024 | 5.13M | -45.20% |
| Dec 29, 2023 | 9.36M | -94.33% |
| Dec 30, 2022 | 165.03M | -54.75% |
| Dec 31, 2021 | 364.69M | 54.35% |
| Dec 31, 2020 | 236.28M | 460.98% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Inno Holdings | 9.80M |
| Odyssey Marine Exploration | 8.34M |
| Gulf Resources | 7.03M |
| Crown Electrokinetics | 6.42M |
| Bon Natural Life | 5.60M |
| Snow Lake Resources | 4.90M |
| Golden Minerals Company | 4.36M |
| SenesTech | 2.41M |